GLOBAL LIQUID BIOPSY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

GLOBAL LIQUID BIOPSY MARKET 2019-2027

Market By Therapeutic Application, Product, Analysis Purpose, End-user, Analysis Platform, Biomarker Type, Clinical Application And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global liquid biopsy market shows that in terms of revenue, the industry is estimated to grow at a CAGR of 21.54% during the forecasting years 2019-2027. The market was assessed to be worth $886.44 million in the year 2018 and is predicted to generate a revenue of approximately $5114.47 million by the year 2027.

Report scope can be customized per your requirements. Request For Customization

Liquid biopsy tests are performed across healthcare and research settings to understand the molecular aspects of cancer. These tests are carried out by hospitals, physicians and pathological & research laboratories and provide the researchers, physicians & surgeons with information about the cancer profile of the patient. This helps in determining appropriate therapy to improve the survival rate of cancer patients. 

A liquid biopsy is performed on a blood sample so that cancer cells can be detected in the circulating blood. A liquid biopsy is one of the most prominent tests that is used to detect cancer at an early stage; it helps in deciding the necessary treatment and also to check for effectiveness of the treatment as well as the repeated occurrence of a tumor, during and after the cancer treatment. Multiple blood samples are taken over some time to understand the molecular changes that take place in a tumor. The study aims to get an overview of the liquid biopsy market in terms of various factors such as the recent trends, technological advancements and the regulatory aspects of the market. Due to the growing demand for non-invasive diagnostic procedures, the global liquid biopsy market is expected to hit an impressive double-digit growth rate over the forecast period. 

Within this report, the market definition and the key insights regarding the liquid biopsy industry have been discussed. Also, Porter's five force analysis, the regulatory framework, key market trends, market attractiveness index and the key initiatives have been studied in detail. 

Market drivers like the increasing cases of cancer in the aging population, increase in different initiatives taken by the government, demand for diagnostic centers, increase in the tissue/tumor-agnostic drugs usage and the growing adoption of precision medicine are driving this market. However, the industry is facing market restraints like the high cost of test and a lack of a consensus on standard operating procedures, which are obstructing the industry growth. Key opportunities like advancement in technology and the increasing number of cancer patients can be leveraged by the industry to reach the projected growth. However, challenges such as the lack of reimbursements and fewer skilled professionals are being faced by this market.

To get detailed insights on segments, Download Sample Report

Geographies covered in the global liquid biopsy market are:

•    North America: the United States and Canada

•    Europe: the United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe

•    Asia-Pacific: Japan, China, India, ASEAN countries, South Korea, Australia & New Zealand and Rest of Asia-Pacific

•   Latin America: Mexico, Brazil and Rest of Latin America

•    The Middle East and Africa: Turkey, the United Arab Emirates, South Africa, Saudi Arabia and Rest of the Middle East & Africa

The liquid biopsy market has been segmented as follows:

•    By Clinical Application

O    Treatment Monitoring

O    Prognosis & Reoccurrence Monitoring

O    Treatment Selection

O    Diagnosis & Screening

•    By Product

O    Circulating Tumor DNA (cTDNA)

O    Cell-Free DNA (cfDNA)

O    Circulating Tumor Cells (CTCs)

O    Extracellular vesicles and Others

•    By Analysis Purpose

O    Monitoring

O    Therapy guidance

O    Diagnosis

O    Early detection/screening

•    By End-User

O    Hospitals

O    Physicians’ office laboratories

O    Clinical diagnostic laboratories

•    By Analysis Platform

O    NGS

O    Microarray

O    PCR

O    Proteomics

O    Other analysis platforms

•    By Biomarker Type

O    Nucleic acids

O    Proteins

O    Extracellular vesicles

O    Cells

•    By Therapeutic Application

O    Lung Cancer

O    Breast Cancer

O    Prostate Cancer

O    Colorectal Cancer

O    Melanoma Cancer

O    Other types of cancer

O    Non-Oncology Applications

The top companies that have been studied in the global liquid biopsy market are Agilent Technologies, Inc., Boston Scientific Corporation, Argon Medical Devices, Inc., B. Braun Melsungen AG, Cintec Medical Ltd., Roche Diagnostics Corporation, Ad-Tech Medical Instrument Corp., I.M.S. Internazionale Medico Scientifica Srl, QIAGEN N.V., Becton, Dickinson, Planmeca Oy, Bio-Rad Laboratories, Inc., Cardinal Health, Inc., Cook Medical, Inc., Fischer Medical Technologies LLC, C. R. Bard, Inc. (acquired by Becton, Dickinson and Company)

The strategic analysis for each of these companies has been covered in detail. The company market share helps to dive into the information about the key market players in this industry and how much hold they have on the market.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL LIQUID BIOPSY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTES

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   THREAT OF RIVALRY

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET TRENDS

2.6. KEY LIQUID BIOPSY INITIATIVES

2.7. MARKET ATTRACTIVENESS INDEX

2.8. MARKET DRIVERS

2.8.1.   CANCER CASES IN OLDER POPULACE ARE SIGNIFICANTLY INCREASING

2.8.2.   INCREASE IN DIFFERENT INITIATIVES TAKEN BY THE GOVERNMENT

2.8.3.   DIAGNOSTIC CENTERS ARE IN DEMAND

2.8.4.   TISSUE/TUMOR-AGNOSTIC DRUGS USAGE ARE INCREASING

2.8.5.   RISE IN USAGE OF PRECISION MEDICINE

2.9. MARKET RESTRAINTS

2.9.1.   HIGH COST OF TEST

2.9.2.   LACK OF A CONSENSUS ON STANDARD OPERATING PROCEDURES (SOPs)

2.10.            MARKET OPPORTUNITIES

2.10.1.                ADVANCEMENT IN TECHNOLOGY

2.10.2.                RISING NUMBER OF CANCER PATIENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF REIMBURSEMENT

2.11.2.                SKILLED PROFESSIONALS ARE QUITE LESS IN NUMBER

3.    LIQUID BIOPSY MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. PROSTATE CANCER

3.2. MELANOMA CANCER

3.3. BREAST CANCER

3.4. COLORECTAL CANCER

3.5. LUNG CANCER

3.6. OTHER TYPES OF CANCER

3.7. NON-ONCOLOGY APPLICATIONS

4.    LIQUID BIOPSY MARKET OUTLOOK - BY PRODUCT

4.1. CELL-FREE DNA (CFDNA)

4.2. CIRCULATING TUMOR CELLS (CTCS)

4.3. CIRCULATING TUMOR DNA (CTDNA)

4.4. EXTRACELLULAR VESICLES AND OTHERS

5.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PURPOSE

5.1. MONITORING

5.2. THERAPY GUIDANCE

5.3. EARLY DETECTION/SCREENING

5.4. DIAGNOSIS

6.    LIQUID BIOPSY MARKET OUTLOOK - BY END-USER

6.1. HOSPITALS

6.2. PHYSICIANS’ OFFICE LABORATORIES

6.3. CLINICAL DIAGNOSTIC LABORATORIES

7.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PLATFORM

7.1. MICROARRAY

7.2. NGS

7.3. PROTEOMICS

7.4. PCR

7.5. OTHER ANALYSIS PLATFORMS

8.    LIQUID BIOPSY MARKET OUTLOOK - BY BIOMARKER TYPE

8.1. NUCLEIC ACIDS

8.2. PROTEINS

8.3. EXTRACELLULAR VESICLES

8.4. CELLS

9.    LIQUID BIOPSY MARKET OUTLOOK - BY CLINICAL APPLICATION

9.1. TREATMENT MONITORING

9.2. PROGNOSIS & REOCCURRENCE MONITORING

9.3. TREATMENT SELECTION

9.4. DIAGNOSIS & SCREENING

10. LIQUID BIOPSY MARKET - REGIONAL OUTLOOK

10.1.            NORTH AMERICA

10.1.1.                MARKET BY THERAPEUTIC APPLICATION

10.1.2.                MARKET BY CLINICAL APPLICATION

10.1.3.                MARKET BY BIOMARKER TYPE

10.1.4.                MARKET BY ANALYSIS PLATFORM

10.1.5.                MARKET BY ANALYSIS PURPOSE

10.1.6.                MARKET BY PRODUCT

10.1.7.                MARKET BY END-USER

10.1.8.                COUNTRY ANALYSIS

10.1.8.1.   THE UNITED STATES

10.1.8.2.   CANADA

10.2.            EUROPE

10.2.1.                MARKET BY THERAPEUTIC APPLICATION

10.2.2.                MARKET BY CLINICAL APPLICATION

10.2.3.                MARKET BY BIOMARKER TYPE

10.2.4.                MARKET BY ANALYSIS PLATFORM

10.2.5.                MARKET BY ANALYSIS PURPOSE

10.2.6.                MARKET BY PRODUCT

10.2.7.                MARKET BY END-USER

10.2.8.                COUNTRY ANALYSIS

10.2.8.1.   THE UNITED KINGDOM

10.2.8.2.   FRANCE

10.2.8.3.   GERMANY

10.2.8.4.   ITALY

10.2.8.5.   SPAIN

10.2.8.6.   RUSSIA

10.2.8.7.   REST OF EUROPE

10.3.            ASIA-PACIFIC

10.3.1.                MARKET BY THERAPEUTIC APPLICATION

10.3.2.                MARKET BY CLINICAL APPLICATION

10.3.3.                MARKET BY BIOMARKER TYPE

10.3.4.                MARKET BY ANALYSIS PLATFORM

10.3.5.                MARKET BY ANALYSIS PURPOSE

10.3.6.                MARKET BY PRODUCT

10.3.7.                MARKET BY END-USER

10.3.8.                COUNTRY ANALYSIS

10.3.8.1.   JAPAN

10.3.8.2.   CHINA

10.3.8.3.   INDIA

10.3.8.4.   SOUTH KOREA

10.3.8.5.   ASEAN COUNTRIES

10.3.8.6.   AUSTRALIA & NEW ZEALAND

10.3.8.7.   REST OF ASIA-PACIFIC

10.4.            LATIN AMERICA

10.4.1.                MARKET BY THERAPEUTIC APPLICATION

10.4.2.                MARKET BY CLINICAL APPLICATION

10.4.3.                MARKET BY BIOMARKER TYPE

10.4.4.                MARKET BY ANALYSIS PLATFORM

10.4.5.                MARKET BY ANALYSIS PURPOSE

10.4.6.                MARKET BY PRODUCT

10.4.7.                MARKET BY END-USER

10.4.8.                COUNTRY ANALYSIS

10.4.8.1.   BRAZIL

10.4.8.2.   MEXICO

10.4.8.3.   REST OF LATIN AMERICA

10.5.            MIDDLE EAST AND AFRICA

10.5.1.                MARKET BY THERAPEUTIC APPLICATION

10.5.2.                MARKET BY CLINICAL APPLICATION

10.5.3.                MARKET BY BIOMARKER TYPE

10.5.4.                MARKET BY ANALYSIS PLATFORM

10.5.5.                MARKET BY ANALYSIS PURPOSE

10.5.6.                MARKET BY PRODUCT

10.5.7.                MARKET BY END-USER

10.5.8.                COUNTRY ANALYSIS

10.5.8.1.   SAUDI ARABIA

10.5.8.2.   TURKEY

10.5.8.3.   THE UNITED ARAB EMIRATES

10.5.8.4.   SOUTH AFRICA

10.5.8.5.   REST OF MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

11.1.            AGILENT TECHNOLOGIES, INC.

11.2.            BOSTON SCIENTIFIC CORPORATION

11.3.            ARGON MEDICAL DEVICES, INC.

11.4.            B. BRAUN MELSUNGEN AG

11.5.            CINTEC MEDICAL LTD.

11.6.            ROCHE DIAGNOSTICS CORPORATION

11.7.            AD-TECH MEDICAL INSTRUMENT CORP.

11.8.            I.M.S. INTERNAZIONALE MEDICO SCIENTIFICA SRL

11.9.            QIAGEN N.V.

11.10.         BECTON, DICKINSON

11.11.         PLANMECA OY

11.12.         BIO-RAD LABORATORIES, INC.

11.13.         CARDINAL HEALTH, INC.

11.14.         COOK MEDICAL, INC.

11.15.         FISCHER MEDICAL TECHNOLOGIES LLC

11.16.         C. R. BARD, INC. (ACQUIRED BY BECTON, DICKINSON AND COMPANY)

12. RESEARCH METHODOLOGY & SCOPE

12.1.            RESEARCH SCOPE & DELIVERABLES

12.1.1.                OBJECTIVES OF STUDY

12.1.2.                SCOPE OF STUDY

12.2.            SOURCES OF DATA

12.2.1.                PRIMARY DATA SOURCES

12.2.2.                SECONDARY DATA SOURCES

12.3.            RESEARCH METHODOLOGY

12.3.1.                EVALUATION OF PROPOSED MARKET

12.3.2.                IDENTIFICATION OF DATA SOURCES

12.3.3.                ASSESSMENT OF MARKET DETERMINANTS

12.3.4.                DATA COLLECTION

12.3.5.                DATA VALIDATION & ANALYSIS

List of table

TABLE 1        GLOBAL LIQUID BIOPSY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        LIQUID BIOPSY BIOMARKER CLASSES

TABLE 3        GOVERNMENT INITIATIVES FOR CANCER AND LIQUID BIOPSY TESTING IN SOME COUNTRIES

TABLE 4        GLOBAL LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 6        GLOBAL LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 7        GLOBAL LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 8        GLOBAL LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 9        ADVANTAGES OF DROPLET DIGITAL PCR FOR SINGLE-CELL ANALYSIS

TABLE 10      DROPLET DIGITAL PCR INDUSTRIES

TABLE 11      GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 12      CELL DIFFERENTIATORS

TABLE 13      GLOBAL LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 14      GLOBAL LIQUID BIOPSY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 15      NORTH AMERICA LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 16      NORTH AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 17      NORTH AMERICA LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 18      NORTH AMERICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 19      NORTH AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 20      NORTH AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 21      NORTH AMERICA LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 22      NORTH AMERICA LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 23      EUROPE LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 24      EUROPE LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 25      EUROPE LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 26      EUROPE LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 27      EUROPE LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 28      EUROPE LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 29      EUROPE LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 30      EUROPE LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 31      ASIA-PACIFIC LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 32      ASIA-PACIFIC LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 33      ASIA-PACIFIC LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 34      ASIA-PACIFIC LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 35      ASIA-PACIFIC LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 36      ASIA-PACIFIC LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 37      ASIA-PACIFIC LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 38      ASIA-PACIFIC LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 39      LATIN AMERICA LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 40      LATIN AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 41      LATIN AMERICA LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 42      LATIN AMERICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 43      LATIN AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 44      LATIN AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 45      LATIN AMERICA LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 46      LATIN AMERICA LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 47      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 48      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 49      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 50      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 51      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 52      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 53      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 54      MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      GLOBAL LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 2      RURAL POPULATIONS IN DEVELOPING COUNTRIES 2017 (%)

FIGURE 3      GLOBAL LIQUID BIOPSY MARKET BY PROSTATE CANCER 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL LIQUID BIOPSY MARKET BY MELANOMA CANCER 2019-2027 ($ MILLION)

FIGURE 5      TYPES OF BREAST CANCER

FIGURE 6      GLOBAL LIQUID BIOPSY MARKET BY BREAST CANCER 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL LIQUID BIOPSY MARKET BY COLORECTAL CANCER 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL LIQUID BIOPSY MARKET BY LUNG CANCER 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL LIQUID BIOPSY MARKET BY OTHER TYPES OF CANCER 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL LIQUID BIOPSY MARKET BY NON-ONCOLOGY APPLICATION 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL LIQUID BIOPSY MARKET BY CELL-FREE DNA (CFDNA) 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL LIQUID BIOPSY MARKET BY CIRCULATING TUMOR CELLS (CTCS) 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL LIQUID BIOPSY MARKET BY CIRCULATING TUMOR DNA (CTDNA) 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES AND OTHERS 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL LIQUID BIOPSY MARKET BY MONITORING 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL LIQUID BIOPSY MARKET BY THERAPY GUIDANCE 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL LIQUID BIOPSY MARKET BY EARLY DETECTION/SCREENING 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL LIQUID BIOPSY MARKET BY DIAGNOSIS 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL LIQUID BIOPSY MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL LIQUID BIOPSY MARKET BY PHYSICIANS’ OFFICE LABORATORIES 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL LIQUID BIOPSY MARKET BY CLINICAL DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL LIQUID BIOPSY MARKET BY MICROARRAY 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL LIQUID BIOPSY MARKET BY NGS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL LIQUID BIOPSY MARKET BY PROTEOMICS 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL LIQUID BIOPSY MARKET BY PCR 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL LIQUID BIOPSY MARKET BY OTHER ANALYSIS PLATFORM 2019-2027 ($ MILLION)

FIGURE 27   GLOBAL LIQUID BIOPSY MARKET BY NUCLEIC ACIDS 2019-2027 ($ MILLION)

FIGURE 28   GLOBAL LIQUID BIOPSY MARKET BY PROTEINS 2019-2027 ($ MILLION)

FIGURE 29   GLOBAL LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES 2019-2027 ($ MILLION)

FIGURE 30   GLOBAL LIQUID BIOPSY MARKET BY CELLS 2019-2027 ($ MILLION)

FIGURE 31   GLOBAL LIQUID BIOPSY MARKET BY TREATMENT MONITORING 2019-2027 ($ MILLION)

FIGURE 32   GLOBAL LIQUID BIOPSY MARKET BY PROGNOSIS & REOCCURRENCE MONITORING 2019-2027 ($ MILLION)

FIGURE 33   GLOBAL LIQUID BIOPSY MARKET BY TREATMENT SELECTION 2019-2027 ($ MILLION)

FIGURE 34   GLOBAL LIQUID BIOPSY MARKET BY DIAGNOSIS & SCREENING 2019-2027 ($ MILLION)

FIGURE 35   NORTH AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 36   THE UNITED STATES LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 37   NEW CANCER CASES & CANCER DEATHS IN THE US 2016-2020 (PER 100,000 PEOPLE)

FIGURE 38   CANADA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 39   EUROPE LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 40   THE UNITED KINGDOM LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 41   FRANCE LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 42   GERMANY LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 43   ITALY LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 44   SPAIN LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 45   RUSSIA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 46   REST OF EUROPE LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 47   ASIA-PACIFIC LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 48   JAPAN LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 49   CHINA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 50   INDIA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 51   SOUTH KOREA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 52   AUSTRALIA & NEW ZEALAND LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 53   ASEAN COUNTRIES LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 54   REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 55   LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 56   BRAZIL LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 57   MEXICO LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 58   REST OF LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 59   MIDDLE EAST AND AFRICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 60   SAUDI ARABIA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 61   TURKEY LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 62   UNITED ARAB EMIRATES LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 63   SOUTH AFRICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 64   REST OF MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;